Movement Alert|MongoDB Inc. Falls 10.49% in Regular Trading, Atlas Growth Misses Elevated Expectations Despite Broad Q2 Beat

Market Focus
Sep 02

On September 2, MongoDB Inc. fell 10.49% in regular trading, trading at 387.25 USD/share, with turnover of approximately $213 million. The sell-off followed the release of strong fiscal Q2 results that nonetheless failed to satisfy elevated investor expectations for the core Atlas cloud database product.

MongoDB reported fiscal Q2 total revenue of $771.8 million, up 30% year-over-year, with Non-GAAP EPS of $1.90 versus the consensus estimate of $1.61, a beat of roughly 18%. The company also raised full-year guidance to revenue of $2.99–$3.03 billion and adjusted EPS of $6.39–$6.58, both above prior Street estimates. Atlas full-year growth expectations were lifted by 300 basis points to approximately 27%.

However, Atlas — which accounts for roughly 74% of total revenue — did not deliver year-over-year growth acceleration, falling short of implicit buy-side expectations. UBS channel checks prior to the report indicated limited tangible AI-driven demand uplift for the MongoDB platform, while Oppenheimer had flagged potential near-term volatility if Atlas failed to accelerate. Combined with a sharp rally in the prior month that left minimal room for error, profit-taking pressure intensified.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10